Find information on thousands of medical conditions and prescription drugs.

Glucobay

Acarbose is a drug used to treat type 2 diabetes mellitus and, in some countries, prediabetes. It is sold in Europe under the brand name Glucobay® (Bayer AG), in North America as Precose® (Bayer AG), and in Canada as Prandase® (Bayer AG). It is an inhibitor of alpha glucosidase, an enteric enzyme that releases glucose from larger carbohydrates. The main side-effect is loose stool or diarrhea, which limits its use, although these effects can be minimised by starting treatment with a low dose and titrating upwards. It is an effective anti-diabetic drug. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
Gabapentin
Gabitril
Galantamine
Gamma-hydroxybutyrate
Ganciclovir
Garamycin
Gaviscon
Gemcitabine
Gemfibrozil
Gemhexal
Gemzar
Generlac
Gentamicin
Geodon
Gleevec
Gliadel
Gliadel Wafer
Glibenclamide
Glimepiride
Glipizide
Glucagon
Glucobay
Glucohexal
Glucophage
Glucosamine
Glucotrol
Glutethimide
Golytely
Gonadorelin
Goserelin
Gramicidin
Gramicidin S
Granisetron
Grifulvin V
Griseofulvin
Guaifenesin
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Acarbose inhibits enzymes needed to digest carbohydrates: apecifically alpha-glucosidase enzymes in the brush broder of the small intestines and it inhibits pancreatic alpha-amylase. Pancreatic alpha-amylase hydrolyzes complex starches to oligosaccharides in the lumen of the small intestine, whereas the membrane-bound intestinal alpha-glucosidases hydrolyze oligosaccharides, trisaccharides, and disaccharides to glucose and other monosaccharides in the small intestine. Inhibition of these enzyme systems reduces the rate of digestion of complex carbohydrates. Less glucose is absorbed because the carbohydrates are not broken down into glucose molecules. In diabetic patients, the short-term effect of these drugs therapies is to decrease current blood glucose levels: the long term effect is a small reduction in hemoglobin A1C level. (From Drug Therapy in Nursing, 2nd ed)

main side effects: flatulence (decreases with time)

Read more at Wikipedia.org


[List your site here Free!]


Starch blocker could prevent diabetes in some
From Milwaukee Journal Sentinel, The, 6/14/02 by EMMA ROSS

Starch blocker could prevent diabetes in some

By EMMA ROSS

Associated Press

Friday, June 14, 2002

London -- A pill that blocks the digestion of starch could prevent or delay the development of the most common form of diabetes in those with slightly high blood sugar, a new study shows.

Experts estimate that more than 200 million people worldwide -- including nearly 16 million Americans -- are pre-diabetic and half will develop diabetes within 10 years. They predict a worldwide explosion by 2025 and say the disease is likely to become history's biggest epidemic.

Although exercise and healthier eating can delay or prevent diabetes for most people, some experts believe that because many people won't heed advice about healthier lifestyles, drugs will be necessary.

A study published this week in The Lancet medical journal found that pre-diabetics who took starch-blocker pills cut by 25% their chances of progressing to diabetes, which is a leading cause of blindness, kidney failure, amputations and heart disease. It is the fourth-leading cause of death in the industrialized world.

Type 1 diabetes, which is not affected by this medication, usually occurs in early childhood and represents 10% of diabetes cases. But 90% are Type 2 diabetes, which usually is acquired later in life. Diabetes impairs the body's production of insulin, a hormone that converts sugar, starches and other food into energy.

The drug tested in the study, acarbose, prevents the breakdown of sugar, so it is expelled from the body undigested and does not reach the bloodstream.

Acarbose, made by Bayer and sold as Precose in the United States and as Glucobay in Europe, has been approved for the treatment of diabetes for nearly 10 years. However, it is not widely used because of unwelcome side effects -- diarrhea and flatulence.

The study, funded by Bayer, involved 1,400 people from nine countries who had pre-diabetes, known scientifically as impaired glucose tolerance.

Some experts were encouraged by the findings, while others believe the drug is not a practical solution.

"It clearly does not make huge sense for people to swallow food and then take tablets to stop them digesting it," said Edwin Gale, a professor of diabetic medicine at the University of Bristol in England who was not connected with the study. "The best thing you can do is take exercise once or twice a week for 20 minutes. That will halve your risk."

Copyright 2002 Journal Sentinel Inc. Note: This notice does not apply to those news items already copyrighted and received through wire services or other media
Provided by ProQuest Information and Learning Company. All rights Reserved.

Return to Glucobay
Home Contact Resources Exchange Links ebay